Quince Therapeutics publishes eDSP study data in pulmonary, IBD disorders

Go back to Quince Therapeutics publishes eDSP study data in pulmonary, IBD disorders
(NASDAQ: QNCX) Delayed: 34.04 +1.63 (5.03%)
Previous Close $32.41    52 Week High
Open $31.78    52 Week Low
Day High $35.20    P/E N/A 
Day Low $31.78    EPS
Volume 26,081